News for Aspen Pharmacare Holdings Limited (APNHY)

Revenue: Up 10% year-over-year.Normalized EBITDA: Up 1% year-over-year.Normalized HEPS: Up 17% in the second half.Operating Cash Flow: Exceeded 100% cash conve

Aspen Pharmacare Holdings Limited (OTCPK:APNHF) Q4 2024 Earnings Conference Call September 4, 2024 2:30 AM ETCompany ParticipantsSibongakonke Nkosi -...

Aspen Pharmacare Holdings Limited (OTCPK:APNHF) Q2 2024 Results Conference Call March 5, 2024 1:30 AM ETCompany ParticipantsSibongakonke Nkosi - Investor...

Global demand for general anesthesia drugs rises with growing chronic disease cases. The United States grapples with shortages of key drugs like...

The growing demand in Australia Oncology market is projected to reach US$ 420.4 million by 2030, with an annual growth rate of 9% ...

An in-depth look at Aspen Pharmacare Holdings Ltd's dividend performance, sustainability, and future prospects Aspen Pharmacare Holdings Ltd(APNHY) recently an

Aspen Pharmacare Holdings Limited (OTCPK:APNHF) Q4 2023 Results Conference Call August 31, 2023 2:30 AM ETCompany ParticipantsSibongakonke N.

South African drugmaker Aspen Pharmacare on Wednesday posted a 4% drop in annual profit impacted by higher inflation and a drop in COVID-19 vaccine sales....

Subject to approval from relevant Competition Authorities, Lilly will enter a strategic agreement with Aspen to continue serving patients and bring innovative therapies to South Africa...

/PRNewswire/ -- The "Generic Drugs Market- Global Industry Size, Share, Trends, Opportunity and Forecast, 2018-2028F By Type (Small Molecule Generics vs...

Thrombus Treatment Market Trends and Insights by Type (Atrial Thrombus [Right Atrial Thrombus and Left Atrial Thrombus] and Venous Thrombus), by Treatment...

Aspen Pharmacare Holdings Limited (OTCPK:APNHF) H1 2023 Earnings Conference Call March 2, 2023 1:30 AM ETCompany ParticipantsStephen Saad – Chief Executive OfficerSean Capazorio – Chief...